Cargando…

Studies for Improving a Rat Model of Alzheimer’s Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory

During the past 15 years, several genetically altered mouse models of human Alzheimer’s disease (AD) have been developed. These costly models have greatly facilitated the evaluation of novel therapeutic approaches. Injecting synthetic β-amyloid (Aβ) 1-42 species into different parts of the brain of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasza, Ágnes, Penke, Botond, Frank, Zsuzsanna, Bozsó, Zsolt, Szegedi, Viktor, Hunya, Ákos, Németh, Klaudia, Kozma, Gábor, Fülöp, Lívia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150403/ https://www.ncbi.nlm.nih.gov/pubmed/29156571 http://dx.doi.org/10.3390/molecules22112007

Ejemplares similares

Abeta(1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors
por: Varga, Edina, et al.
Publicado: (2014)

Simultaneous Changes of Spatial Memory and Spine Density after Intrahippocampal Administration of Fibrillar Aβ (1–42) to the Rat Brain
por: Borbély, Emőke, et al.
Publicado: (2014)

A Foldamer-Dendrimer Conjugate Neutralizes Synaptotoxic β-Amyloid Oligomers
por: Fülöp, Lívia, et al.
Publicado: (2012)

Acute intracerebral treatment with amyloid-beta (1–42) alters the profile of neuronal oscillations that accompany LTP induction and results in impaired LTP in freely behaving rats
por: Kalweit, Alexander Nikolai, et al.
Publicado: (2015)

Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ(1–42)-Injected, Wild-Type Mouse Model of AD
por: Borbély, Emőke, et al.
Publicado: (2022)

Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers
por: Bartus, Éva, et al.
Publicado: (2018)

β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
por: Penke, Botond, et al.
Publicado: (2017)

Examination of Longitudinal Alterations in Alzheimer’s Disease-Related Neurogenesis in an APP/PS1 Transgenic Mouse Model, and the Effects of P33, a Putative Neuroprotective Agent Thereon
por: Szögi, Titanilla, et al.
Publicado: (2022)

Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer’s Disease
por: Kasza, Ágnes, et al.
Publicado: (2016)

Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice: A Novel Mechanism Presenting the Protein Fe65 as a Target
por: Szögi, Titanilla, et al.
Publicado: (2019)

Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands
por: Bogár, Ferenc, et al.
Publicado: (2022)

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases
por: Penke, Botond, et al.
Publicado: (2018)

GluA1 Phosphorylation Alters Evoked Firing Pattern In Vivo
por: Barkóczi, Balázs, et al.
Publicado: (2012)

Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils
por: Ahmed, Mahiuddin, et al.
Publicado: (2010)

Critical aggregation concentration for the formation of early Amyloid-β (1–42) oligomers
por: Novo, Mercedes, et al.
Publicado: (2018)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
por: Izzo, Nicholas J., et al.
Publicado: (2014)

The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ(1-42) Rat Model with Pinealectomy
por: Tzoneva, Rumiana, et al.
Publicado: (2021)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
por: Rosenberry, Terrone L., et al.
Publicado: (2022)

Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice
por: Lénárt, Nikolett, et al.
Publicado: (2012)

Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
por: Penke, Botond, et al.
Publicado: (2020)

Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)

Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
por: Baldassarre, Maurizio, et al.
Publicado: (2017)

Novel High Affinity Sigma-1 Receptor Ligands from Minimal Ensemble Docking-Based Virtual Screening
por: Dvorácskó, Szabolcs, et al.
Publicado: (2021)

Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function
por: Barucker, Christian, et al.
Publicado: (2015)

Construction of human Fab library and screening of a single-domain antibody of amyloid-beta 42 oligomers
por: Yuan, Zuanning, et al.
Publicado: (2013)

Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
por: Zhang, Yuan, et al.
Publicado: (2019)

Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β(1–42) Oligomers
por: Wang, Li-Sha, et al.
Publicado: (2019)

SLID-ICV Vertical Integration Technology for the ATLAS Pixel Upgrades
por: Macchiolo, A., et al.
Publicado: (2012)

Intra‐gastrointestinal amyloid‐β1–42 oligomers perturb enteric function and induce Alzheimer's disease pathology
por: Sun, Yayi, et al.
Publicado: (2020)

Characterization of Homogeneous and Heterogeneous Amyloid-β42 Oligomer Preparations with Biochemical Methods and Infrared Spectroscopy Reveals a Correlation between Infrared Spectrum and Oligomer Size
por: Vosough, Faraz, et al.
Publicado: (2021)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

ICV196VME : ITX interface driver: Using DSC at PS
por: BERLIN, F., et al.
Publicado: (1993)

T1 mapping, ECV and ICV before and after aortic valve replacement
por: Vermes, Emmanuelle, et al.
Publicado: (2015)

Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits
por: Singh, Navdeep, et al.
Publicado: (2017)

Effects of sub-chronic, in vivo administration of sigma-1 receptor ligands on platelet and aortic arachidonate cascade in streptozotocin-induced diabetic rats
por: Váczi, Sándor, et al.
Publicado: (2022)

Neurodegeneration-related beta-amyloid as autocatabolism-attenuator in a micro-in vivo system
por: Balazs, Evelin, et al.
Publicado: (2020)

β-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons
por: Wicklund, Linn, et al.
Publicado: (2010)

Cryo‐electron Microscopy Imaging of Alzheimer's Amyloid‐beta 42 Oligomer Displayed on a Functionally and Structurally Relevant Scaffold
por: Wu, Jinming, et al.
Publicado: (2021)

Amyloid β(1–42) Oligomers Induce Galectin–1(S8) O–GlcNAcylation Leading to Microglia Migration
por: Arrazola Sastre, Alazne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qhoa8lq2m486i1u2nlbnjov1el